Pharmacogenomics of the OATP and OAT families

Pharmacogenomics

Volumn 5, Issue 3, 2004, Pages 273-282

  Marzolini, Catia ^a   Tirona, Rommel G ^a,b   Kim, Richard B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

Drug uptake transporter; Pharmacokinetics; Single nucleotide polymorphism

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CERIVASTATIN; CIMETIDINE; DELTORPHIN; DIGOXIN; DIURETIC AGENT; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FEXOFENADINE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; NONSTEROID ANTIINFLAMMATORY AGENT; OCHRATOXIN; ORGANIC ANION TRANSPORTER; OUABAIN; PENICILLIN G; PHALLOIDIN; PRAVASTATIN; PROSTAGLANDIN E2; QUINIDINE; QUINIDINE DERIVATIVE; RIFAMPICIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROCURONIUM; ROSUVASTATIN; SALICYLIC ACID; UNINDEXED DRUG; ZIDOVUDINE;

CELL TRANSPORT; DNA POLYMORPHISM; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RESPONSE; DRUG TRANSPORT; DRUG UPTAKE; ETHNIC DIFFERENCE; GENETIC VARIABILITY; HUMAN; INTESTINE; KIDNEY; LIVER; PHARMACOGENOMICS; PROTEIN FAMILY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; ORGANIC ANION TRANSPORTERS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 9944261686     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/phgs.5.3.273.29831     Document Type: Review

References (55)

1. Lin JH, Yamazaki M: Role of P-glycoprotein in Pharmacokinetics. Clin. Pharmacokinet. 42, 59-98 (2003).
2. Tamai I, Nezu JI, Uchino H et al.: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Com. 273, 251-260 (2000).
3. Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ: Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc. Natl. Acad. Sci. USA 91, 133-137 (1994).
4. Hagenbuch B, Meier PJ: Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch. 447(5), 653-665 (2004).
5. Kullak-Ublick GA, Hagenbuch B, Stieger B et al.: Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109, 1274-1282 (1995).
6. Abe T, Kakyo M, Tokui T et al.: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J. Biol. Chem. 120, 17159-17163 (1999).
7. Bergwerk AJ, Shi AC, Ford N et al.: Immunologic distribution of an organic anion transport protein in rat liver and kidney. Am. J. Physiol. 271, G231-G238 (1996).
8. Angeletti RH, Novikoff PM, Juvvadi SR, Fritschy JM, Meier PJ, Wolkoff AW. The choroids plexus epithelium is the site of the organic anion transport protein in the brain. Proc. Natl. Acad. Sci. USA 94, 283-286 (1994).
9. Kullak-Ublick GA, Fisch T, Oswald M et al.: Dehydroepiandrosterone sulphate (DHEAS): identification of a carrier protein in human liver and brain. FEBS Lett. 424, 173-176 (1998).
10. Bossuyt X, Muller M, Meier PJ: Multispecific amphipathic substrate transport by an organic anion transporter of human liver. J. Hepatol. 25, 733-738 (1996).
11. Kullak-Ublick GA, Ismair MG, Stieger B et al.: Organic anion-transporting polypeptide B [OATP-B] and its functional comparison with three other OATPs of human liver. Gastroenterology 120, 525-533 (2001).
12. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke B, Aguzzi A, Meier PJ: Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. 294, 73-79 (2000).
13. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB: OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab. Dispos. 27, 866-871 (1999).
14. Iida A, Saito S, Sekine A et al.: Catalog of 258 single-nucleotide polymorphisms (SNPs) in genes encoding three organic anion transporters, three organic anion-transporting polypeptide, and three NADH: ubiquinone oxidoreductase flavoproteins. J. Hum. Genet. 46, 668-683 (2001).
15. Lee W, Smith LH, Gervasini G, Leake BF, Kim RB: Identification of nonsynonomous polymorphisms of human organic anion transporting polypeptide-A (OATP-A) associated with altered transport activity. 105th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Florida, USA (2004) (Abstract).
16. Kobayashi D, Nozawa T, Imai K et al.: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J. Pharmacol. Exp. Ther. 306, 703-708 (2003).
17. Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J. Pharmacol. Exp. Ther. 308, 438-445 (2004).
18. Nozawa T, Nakajima M, Tamai I et al.: Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATPB (SLC21A9): allele frequencies in the Japanese population and functional analysis. J. Pharmacol. Exp. Ther. 302, 804-813 (2002).
19. Hsiang B, Zhu Y, Wang Z et al.: A novel human hepatic organic anion transporting polypeptide 2 (OATP2): identification of a liver-specific organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA-reductase inhibitor transporters. J. Biol. Chem. 274, 37161-37168 (1999).
20. Konig J, Cui Y, Nies AT et al.: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver. Physiol 278, G156-G164 (2000).
21. Nakai D, Nakagomi R, Furuta Y et al.: Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes. J. Pharmacol. Exp. Ther. 297, 861-867 (2001).
22. Tirona RG, Leake BF, Merino G, Kim RB: Polymorphisms in OATP-C. Identification of multiple allelic variants associated with altered transport activity among European-and African-Americans. J. Biol. Chem. 276, 35669-35675 (2001).
23. Tirona RG, Leake BF, Wulkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J. Pharmacol. Exp. Ther. 304, 223-228 (2003).
24. Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y: Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and ciclosporin A. J. Pharmacol. Exp. Ther. 304, 610-616 (2003).
25. Bolego C, Poli A, Cignarella A, Catapano AL, Paoletti R: Novel statins: pharmacological and clinical results. Cardiovasc. Drugs Ther. 16, 251-257 (2002).
26. Michalski C, Cui Y, Nies AT et al.: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J. Biol. Chem. 277, 43058-43063 (2002).
27. Nishizato Y, Ieiri I, Suzuki H et al.: Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin. Pharm. Ther. 73, 554-65 (2003).
28. Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J. Biol. Chem. 275, 23161-23168 (2000).
29. Adachi H, Suzuki T, Abe M, Asano N et al.: Molecular characterization of human and rat organic anion transporter OATP-D. Am. J. Physiol. Renal. Physiol. 285, F1188-F1197 (2003).
30. Fujiwara K, Adachi H, Nishio T et al.: Identification of thyroid hormone transporters in humans : different molecules are involved in a tissue-specific manner. Endocrinology 142, 2005-2012 (2001).
31. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ: Identification of a novel human organic anion transporting polypeptide (OATP-F) as a high affinity thyroxine transporter. Mol. Endrocrinol. 16, 2283-2296 (2002).
32. Suzuki T, Onogawa T, Asano N et al.: Identification and characterization of novel rat and human gonad specific organic anion transporters. Mol. Endocrinol. 17, 1203-1215 (2003).
33. Lu R, Kanai N, Bao Y, Schuster VL: Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (HPGT). J. Clin. Invest. 98, 1142-1149 (1996).
34. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H: Expression cloning and characterization of a novel multispecific organic anion transporter. J. Biol. Chem. 272, 18526-18529 (1997).
35. Hosoyamada M, Sekine T, Kanai Y, Endou H: Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am. J. Physiol. 276, F122-F128 (1999).
36. Lu R, Chan BS, Schuster VL: Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C. Am. J. Physiol. 276, F295-F303 (1999).
37. Race JE, Grassi SM, Williams WJ, Holtzman EJ: Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem. Biophys. Res. Commun. 255, 508-514 (1999).
38. Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH: The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol. Pharmacol. 56, 570-580 (1999).
39. Cihlar T, Ho ES, Lin DC, Mulato AS: Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 20, 641-648 (2001).
40. Ho ES, Lin DC, Mendel DB, Cihlar T: Citotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11, 383-393 (2000).
41. Bleasky K, Mohrenweiser HW, Pritchard JB: Identification of single nucleotide polymorphisms in the human organic anion transporter hOAT1. Drug Metab. Rev. 34(1), S165 (2002).
42. Lee W, Ingram AD, Leake BF, Kim RB: Identification of nonsynonymous polymorphisms of human organic anion transporter 1 (OAT1) among African-, European- and Chinese-American subjects. Drug Metab. Rev. 35, 75 (Abstract 149), (2003).
43. Simonson GD, Vincent AC, Roberg KJ, Huang Y, Iwanij V: Molecular cloning and characterization of a novel liver-specific transport protein. J. Cell. Sci. 107, 1065-1072 (1994).
44. Sekine T, Cha SH, Tsuda M et al.: Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 429, 179-182 (1998).
45. Enomoto A, Takeda M, Shimoda M et al.: Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J. Pharmacol. Exp. Ther. 301, 797-802 (2002).
46. Morita N, Kusuhara H, Sekine T, Endou H, Sugiyama Y: Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. J. Pharmacol. Exp. Ther. 298, 1179-1184 (2001).
47. Cha SH, Sekine T, Fukushima JI et al.: Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol. 59, 1277-1286 (2001).
48. Hasegawa M, Kusuhara H, Sugiyama D et al.: Functional involvement of rat organic transporter 3 (rOat3, Slc22a8) in the renal uptake of organic anions. J. Pharmacol. Exp. Ther. 300, 746-753 (2002).
49. Cha SH, Sekine T, Kusuhara H et al.: Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J. Biol. Chem. 275, 4507-4512 (2000).
50. Babu E, Takeda M, Narikawa S et al.: Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim. Biophys. Acta 1590, 64-75 (2002).
51. Takeda M, Khamdang S, Narikawa S et al.: Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J. Pharmacol. Exp. Ther. 300, 918-924 (2002).
52. Takeda M, Khamdang S, Narikawa S et al.: Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther. 302, 666-671 (2002).
53. van Montfoort JE, Hagenbuch B, Groothuis GMM, Koepsell H, Meier PJ, Meijer DKF: Drug uptake systems in liver and kidney. Current Drug Metab. 4, 185-211 (2003)
54. Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A: Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-1a2, D-Leu5]-enkephalin. J. Pharm. Pharmacol. 55, 1013-1020 (2003).
55. Fehrenbach T, Cui Y, Faulstich H, Keppler D: Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. Naunyn Schmiedebergs Arch. 368, 415-420 (2003).